🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The support from Carolyn Bertozzi , all members of the Bertozzi lab community, Sarafan ChEM-H , Stanford Chemistry and my teammates at OliLux Biosciences Olilux Biosciences Widya Mulyasasmita and the twitterless Ruby Dewi is what made this work possible. 2/5

Show stopper: these are TB-causing cells detected with our #DMN-Tre probe in ***blood samples*** - a first! The paper is in the works and stay tuned for the preprint. Pic credit: David Barr from Graeme Meintjes lab. #StopTB #SmartProbes #TBDx

Seeing is believing! Olilux Biosciences

Some personal news: today I'm starting a new job as head of comms/PR at Resilience, a company that aims to change the way medicine is made, by creating new & better ways of manufacturing therapies. I'm excited to join a fantastic & talented team + work on this important mission!

Mireille Kamariza's invention — a portable diagnostic tool to detect tuberculosis — could help identify more cases faster, anywhere in the world, to prevent further spread, get treatment to those in need, and monitor the effectiveness of treatment hrvd.me/kamariza607t

Exciting news from Olilux Biosciences ! Watch out for rapid assays to detect drug-resistant #TB in the future! 🧫🔬 #StopTB

Following the departure of four stellar postdocs (Zheng Hu, Jennifer Caswell-Jin, José A. Seoane, Kasper Karlsson) who have launched independent careers in the past year, the Curtis Lab (med.stanford.edu/curtislab.html) is recruiting postdocs and computational staff scientists.

We've closed a $50M financing to take our 3-in-1 #myxoma #immunotherapy into #clinicaltrials. oncomyx.com/oncomyx-closes… Lumira Ventures B Capital, LYZZ Capital, Xeraya Capital City Hill Ventures Arizona State University Biodesign Institute at Arizona State University, Skysong Innovations, AZBio @Biomed_PHX Phoenix Community and Economic Development Mayor Kate Gallego

Big news from the MIF, our venture philanthropy fund. Triumvira Immunologics has been added to its list of portfolio companies. The investment will support development of Triumvira’s (TAC)-T cell therapy programs for the treatment of #myeloma. Learn more: ow.ly/5srR50IlGPZ

We are excited and proud to announce our investment in Triumvira Immunologics. Our funding will support the continued preclinical and clinical development of Triumvira’s TAC-T cell programs. Congratulations to the Triumvira team! cc: Robert Mittendorff, MD, MBA businesswire.com/news/home/2022…

Triumvira Immunologics Raises $100M in Series A Funding. The Austin, Texas-based company plans to use the funds to develop its T-cell antigen coupler (TAC)-T cell therapy programs. ow.ly/SZEJ103ucol

Big news indeed! We at B Capital are thrilled to join Multiple Myeloma RF to support *Triumvira* as it establishes TAC-T cell therapies in the clinic.

Exciting update from B Capital’s portfolio company Triumvira Immunologics, showing promising early clinical results in solid tumor TAC T cell therapy. #ESMO22

So fun joining BIOS on this podcast. Thanks for hosting!

Payroll coming next week, many startups have funds locked up with SVB FDIC VCs are going to need to bridge with simple loans to cover near-term working capital Syndicates need to fully participate in helping here. Big reputation blackmark for those investors that don’t step up

Check out our first investment report to see what kind of deals VCs are making at Bakar Labs & what technologies they're backing. More evidence in favor of #UCBerkeley's #1 ranking in supporting venture-backed startups! bakarlabs.berkeley.edu/investment-upd… Darren Cooke - Berkeley LSEC Rich Lyons